HEADER HYDROLASE 22-DEC-14 4UEZ TITLE CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH THE TITLE 2 PHOSPHINIC INHIBITOR ACETYL-LEU-PHE-Y(PO2CH2)-PHE-OH COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN CARBOXYPEPTIDASE A1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CARBOXYPEPTIDASE DOMAIN, UNP RESIDUES 111-419; COMPND 5 EC: 3.4.17.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PANCREATIC; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: KM71H; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PPICZ-ALPHA KEYWDS HYDROLASE, CARBOXYPEPTIDASE, CPA1, PHOSPHINIC INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR P.GALLEGO,G.COVALEDA,L.COSTENARO,L.DEVEL,V.DIVE,F.X.AVILES,D.REVERTER REVDAT 2 20-DEC-23 4UEZ 1 REMARK LINK REVDAT 1 20-JAN-16 4UEZ 0 JRNL AUTH P.GALLEGO,G.COVALEDA,L.DEVEL,V.DIVE,F.X.AVILES,D.REVERTER JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN JRNL TITL 2 COMPLEX WITH PHOSPHINIC INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 26789 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.153 REMARK 3 R VALUE (WORKING SET) : 0.150 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1408 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.35 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1657 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.81 REMARK 3 BIN R VALUE (WORKING SET) : 0.1530 REMARK 3 BIN FREE R VALUE SET COUNT : 72 REMARK 3 BIN FREE R VALUE : 0.2060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4865 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 277 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.31000 REMARK 3 B22 (A**2) : -0.33000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.333 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.212 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.131 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.232 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5112 ; 0.022 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6966 ; 1.731 ; 1.939 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 619 ; 6.434 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 230 ;33.308 ;24.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 795 ;13.904 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;14.925 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 759 ; 0.121 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3923 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3067 ; 0.929 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4966 ; 1.702 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2045 ; 2.828 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2000 ; 4.427 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4UEZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1290062612. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979493 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XPS REMARK 200 DATA SCALING SOFTWARE : CCP4I REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28256 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 45.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.15000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 8.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2V77 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M CALCIUM CHLORIDE, 0.1 M HEPES PH REMARK 280 7.0 AND 17% W/V PEG6000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.99450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.00250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.07150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.00250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.99450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.07150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 111 REMARK 465 ARG A 112 REMARK 465 TYR A 419 REMARK 465 ALA B 111 REMARK 465 TYR B 419 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 283 CG GLU A 283 CD 0.093 REMARK 500 THR A 378 CB THR A 378 CG2 -0.300 REMARK 500 TYR B 158 CD1 TYR B 158 CE1 0.092 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR A 378 CA - CB - CG2 ANGL. DEV. = 11.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 232 -48.13 -138.64 REMARK 500 SER A 309 -7.12 147.93 REMARK 500 ILE A 357 -77.37 -133.27 REMARK 500 ASP A 383 -140.15 -105.66 REMARK 500 LEU A 390 43.52 -92.18 REMARK 500 LYS B 168 64.20 36.72 REMARK 500 THR B 232 -44.96 -137.08 REMARK 500 SER B 309 -9.94 148.54 REMARK 500 ILE B 357 -71.61 -135.82 REMARK 500 ASP B 383 -140.35 -111.49 REMARK 500 LEU B 390 36.93 -88.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 420 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 179 ND1 REMARK 620 2 GLU A 182 OE2 102.4 REMARK 620 3 GLU A 182 OE1 119.2 54.4 REMARK 620 4 HIS A 306 ND1 103.1 138.9 85.0 REMARK 620 5 LFF A 421 O22 136.0 90.8 102.7 92.7 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 420 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 179 ND1 REMARK 620 2 GLU B 182 OE1 114.9 REMARK 620 3 GLU B 182 OE2 95.7 53.0 REMARK 620 4 HIS B 306 ND1 104.5 83.8 136.8 REMARK 620 5 LFF B 421 O22 135.6 105.8 94.8 96.5 REMARK 620 6 LFF B 421 O23 77.6 144.4 94.1 127.1 58.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 420 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LFF A 421 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 420 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LFF B 421 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UEE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH REMARK 900 THE PHOSPHINIC INHBITOR ACETYL-LEU-ALA-Y (PO2CH2)-HOMOPHE-OH REMARK 900 RELATED ID: 4UEF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH REMARK 900 THE PHOSPHINIC INHBITOR ACETYL-TYR-ALA-Y (PO2CH2)-HOMOPHE-OH REMARK 900 RELATED ID: 4UF4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH REMARK 900 A THIIRANE MECHANISM-BASED INHIBITOR REMARK 900 RELATED ID: 5AEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN SENP2 C548S IN COMPLEX WITH THE REMARK 900 HUMAN SUMO1 K48M F66W DBREF 4UEZ A 111 419 UNP P15085 CBPA1_HUMAN 111 419 DBREF 4UEZ B 111 419 UNP P15085 CBPA1_HUMAN 111 419 SEQRES 1 A 309 ALA ARG SER THR ASP THR PHE ASN TYR ALA THR TYR HIS SEQRES 2 A 309 THR LEU GLU GLU ILE TYR ASP PHE LEU ASP LEU LEU VAL SEQRES 3 A 309 ALA GLU ASN PRO HIS LEU VAL SER LYS ILE GLN ILE GLY SEQRES 4 A 309 ASN THR TYR GLU GLY ARG PRO ILE TYR VAL LEU LYS PHE SEQRES 5 A 309 SER THR GLY GLY SER LYS ARG PRO ALA ILE TRP ILE ASP SEQRES 6 A 309 THR GLY ILE HIS SER ARG GLU TRP VAL THR GLN ALA SER SEQRES 7 A 309 GLY VAL TRP PHE ALA LYS LYS ILE THR GLN ASP TYR GLY SEQRES 8 A 309 GLN ASP ALA ALA PHE THR ALA ILE LEU ASP THR LEU ASP SEQRES 9 A 309 ILE PHE LEU GLU ILE VAL THR ASN PRO ASP GLY PHE ALA SEQRES 10 A 309 PHE THR HIS SER THR ASN ARG MET TRP ARG LYS THR ARG SEQRES 11 A 309 SER HIS THR ALA GLY SER LEU CYS ILE GLY VAL ASP PRO SEQRES 12 A 309 ASN ARG ASN TRP ASP ALA GLY PHE GLY LEU SER GLY ALA SEQRES 13 A 309 SER SER ASN PRO CYS SER GLU THR TYR HIS GLY LYS PHE SEQRES 14 A 309 ALA ASN SER GLU VAL GLU VAL LYS SER ILE VAL ASP PHE SEQRES 15 A 309 VAL LYS ASP HIS GLY ASN ILE LYS ALA PHE ILE SER ILE SEQRES 16 A 309 HIS SER TYR SER GLN LEU LEU MET TYR PRO TYR GLY TYR SEQRES 17 A 309 LYS THR GLU PRO VAL PRO ASP GLN ASP GLU LEU ASP GLN SEQRES 18 A 309 LEU SER LYS ALA ALA VAL THR ALA LEU ALA SER LEU TYR SEQRES 19 A 309 GLY THR LYS PHE ASN TYR GLY SER ILE ILE LYS ALA ILE SEQRES 20 A 309 TYR GLN ALA SER GLY SER THR ILE ASP TRP THR TYR SER SEQRES 21 A 309 GLN GLY ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP SEQRES 22 A 309 THR GLY ARG TYR GLY PHE LEU LEU PRO ALA SER GLN ILE SEQRES 23 A 309 ILE PRO THR ALA LYS GLU THR TRP LEU ALA LEU LEU THR SEQRES 24 A 309 ILE MET GLU HIS THR LEU ASN HIS PRO TYR SEQRES 1 B 309 ALA ARG SER THR ASP THR PHE ASN TYR ALA THR TYR HIS SEQRES 2 B 309 THR LEU GLU GLU ILE TYR ASP PHE LEU ASP LEU LEU VAL SEQRES 3 B 309 ALA GLU ASN PRO HIS LEU VAL SER LYS ILE GLN ILE GLY SEQRES 4 B 309 ASN THR TYR GLU GLY ARG PRO ILE TYR VAL LEU LYS PHE SEQRES 5 B 309 SER THR GLY GLY SER LYS ARG PRO ALA ILE TRP ILE ASP SEQRES 6 B 309 THR GLY ILE HIS SER ARG GLU TRP VAL THR GLN ALA SER SEQRES 7 B 309 GLY VAL TRP PHE ALA LYS LYS ILE THR GLN ASP TYR GLY SEQRES 8 B 309 GLN ASP ALA ALA PHE THR ALA ILE LEU ASP THR LEU ASP SEQRES 9 B 309 ILE PHE LEU GLU ILE VAL THR ASN PRO ASP GLY PHE ALA SEQRES 10 B 309 PHE THR HIS SER THR ASN ARG MET TRP ARG LYS THR ARG SEQRES 11 B 309 SER HIS THR ALA GLY SER LEU CYS ILE GLY VAL ASP PRO SEQRES 12 B 309 ASN ARG ASN TRP ASP ALA GLY PHE GLY LEU SER GLY ALA SEQRES 13 B 309 SER SER ASN PRO CYS SER GLU THR TYR HIS GLY LYS PHE SEQRES 14 B 309 ALA ASN SER GLU VAL GLU VAL LYS SER ILE VAL ASP PHE SEQRES 15 B 309 VAL LYS ASP HIS GLY ASN ILE LYS ALA PHE ILE SER ILE SEQRES 16 B 309 HIS SER TYR SER GLN LEU LEU MET TYR PRO TYR GLY TYR SEQRES 17 B 309 LYS THR GLU PRO VAL PRO ASP GLN ASP GLU LEU ASP GLN SEQRES 18 B 309 LEU SER LYS ALA ALA VAL THR ALA LEU ALA SER LEU TYR SEQRES 19 B 309 GLY THR LYS PHE ASN TYR GLY SER ILE ILE LYS ALA ILE SEQRES 20 B 309 TYR GLN ALA SER GLY SER THR ILE ASP TRP THR TYR SER SEQRES 21 B 309 GLN GLY ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP SEQRES 22 B 309 THR GLY ARG TYR GLY PHE LEU LEU PRO ALA SER GLN ILE SEQRES 23 B 309 ILE PRO THR ALA LYS GLU THR TRP LEU ALA LEU LEU THR SEQRES 24 B 309 ILE MET GLU HIS THR LEU ASN HIS PRO TYR HET ZN A 420 1 HET LFF A 421 35 HET ZN B 420 1 HET LFF B 421 35 HETNAM ZN ZINC ION HETNAM LFF (2S)-3-[(R)-{(1R)-1-[(N-ACETYL-L-LEUCYL)AMINO]-2- HETNAM 2 LFF PHENYLETHYL}(HYDROXY)PHOSPHORYL]-2-BENZYLPROPANOIC HETNAM 3 LFF ACID HETSYN LFF ACETYL-LEU-PHE-Y(PO2CH2)-PHE-OH FORMUL 3 ZN 2(ZN 2+) FORMUL 4 LFF 2(C26 H35 N2 O6 P 1-) FORMUL 7 HOH *277(H2 O) HELIX 1 1 THR A 124 ASN A 139 1 16 HELIX 2 2 GLU A 182 TYR A 200 1 19 HELIX 3 3 ASP A 203 ASP A 211 1 9 HELIX 4 4 ASN A 222 THR A 232 1 11 HELIX 5 5 GLU A 283 GLY A 297 1 15 HELIX 6 6 ASP A 325 SER A 342 1 18 HELIX 7 7 ILE A 353 ILE A 357 1 5 HELIX 8 8 SER A 363 GLN A 371 1 9 HELIX 9 9 PRO A 392 SER A 394 5 3 HELIX 10 10 GLN A 395 HIS A 417 1 23 HELIX 11 11 THR B 124 ASN B 139 1 16 HELIX 12 12 GLU B 182 TYR B 200 1 19 HELIX 13 13 ASP B 203 LEU B 213 1 11 HELIX 14 14 ASN B 222 THR B 232 1 11 HELIX 15 15 ASP B 252 ASN B 256 5 5 HELIX 16 16 GLU B 283 GLY B 297 1 15 HELIX 17 17 ASP B 325 SER B 342 1 18 HELIX 18 18 ILE B 353 ILE B 357 1 5 HELIX 19 19 SER B 363 GLN B 371 1 9 HELIX 20 20 TYR B 387 LEU B 391 5 5 HELIX 21 21 PRO B 392 SER B 394 5 3 HELIX 22 22 GLN B 395 HIS B 417 1 23 SHEET 1 AA 8 VAL A 143 ASN A 150 0 SHEET 2 AA 8 PRO A 156 PHE A 162 -1 O ILE A 157 N ILE A 148 SHEET 3 AA 8 ASP A 214 GLU A 218 -1 O ILE A 215 N PHE A 162 SHEET 4 AA 8 ALA A 171 THR A 176 1 O ILE A 172 N PHE A 216 SHEET 5 AA 8 ILE A 299 HIS A 306 1 N LYS A 300 O ALA A 171 SHEET 6 AA 8 TYR A 375 GLU A 380 1 O TYR A 375 N PHE A 302 SHEET 7 AA 8 LEU A 311 TYR A 314 -1 O LEU A 311 N GLU A 380 SHEET 8 AA 8 ASN A 349 SER A 352 1 O ASN A 349 N LEU A 312 SHEET 1 BA 8 VAL B 143 ASN B 150 0 SHEET 2 BA 8 PRO B 156 PHE B 162 -1 O ILE B 157 N ILE B 148 SHEET 3 BA 8 ASP B 214 GLU B 218 -1 O ILE B 215 N PHE B 162 SHEET 4 BA 8 ALA B 171 THR B 176 1 O ILE B 172 N PHE B 216 SHEET 5 BA 8 ILE B 299 HIS B 306 1 N LYS B 300 O ALA B 171 SHEET 6 BA 8 TYR B 375 GLU B 380 1 O TYR B 375 N PHE B 302 SHEET 7 BA 8 LEU B 311 TYR B 314 -1 O LEU B 311 N GLU B 380 SHEET 8 BA 8 ASN B 349 SER B 352 1 O ASN B 349 N LEU B 312 SSBOND 1 CYS A 248 CYS A 271 1555 1555 2.14 SSBOND 2 CYS B 248 CYS B 271 1555 1555 2.10 LINK ND1 HIS A 179 ZN ZN A 420 1555 1555 1.97 LINK OE2 GLU A 182 ZN ZN A 420 1555 1555 2.01 LINK OE1 GLU A 182 ZN ZN A 420 1555 1555 2.62 LINK ND1 HIS A 306 ZN ZN A 420 1555 1555 2.00 LINK ZN ZN A 420 O22 LFF A 421 1555 1555 2.18 LINK ND1 HIS B 179 ZN ZN B 420 1555 1555 2.03 LINK OE1 GLU B 182 ZN ZN B 420 1555 1555 2.63 LINK OE2 GLU B 182 ZN ZN B 420 1555 1555 2.06 LINK ND1 HIS B 306 ZN ZN B 420 1555 1555 2.02 LINK ZN ZN B 420 O22 LFF B 421 1555 1555 2.15 LINK ZN ZN B 420 O23 LFF B 421 1555 1555 2.63 CISPEP 1 SER A 307 TYR A 308 0 2.83 CISPEP 2 PRO A 315 TYR A 316 0 -2.20 CISPEP 3 ARG A 382 ASP A 383 0 -9.85 CISPEP 4 SER B 307 TYR B 308 0 -2.43 CISPEP 5 PRO B 315 TYR B 316 0 9.32 CISPEP 6 ARG B 382 ASP B 383 0 -1.00 SITE 1 AC1 4 HIS A 179 GLU A 182 HIS A 306 LFF A 421 SITE 1 AC2 23 HIS A 179 ARG A 181 GLU A 182 ARG A 237 SITE 2 AC2 23 ASN A 254 ARG A 255 GLU A 273 HIS A 306 SITE 3 AC2 23 SER A 307 TYR A 308 SER A 309 ILE A 353 SITE 4 AC2 23 ILE A 357 TYR A 358 ALA A 360 SER A 363 SITE 5 AC2 23 THR A 378 GLU A 380 PHE A 389 ZN A 420 SITE 6 AC2 23 HOH A2045 GLU B 273 LFF B 421 SITE 1 AC3 4 HIS B 179 GLU B 182 HIS B 306 LFF B 421 SITE 1 AC4 23 GLU A 273 LFF A 421 HIS B 179 ARG B 181 SITE 2 AC4 23 GLU B 182 ARG B 237 ASN B 254 ARG B 255 SITE 3 AC4 23 THR B 274 HIS B 306 SER B 307 TYR B 308 SITE 4 AC4 23 SER B 309 ILE B 353 ILE B 357 TYR B 358 SITE 5 AC4 23 ALA B 360 SER B 363 THR B 378 GLU B 380 SITE 6 AC4 23 PHE B 389 ZN B 420 HOH B2047 CRYST1 45.989 84.143 158.005 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021744 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011885 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006329 0.00000